[Importance of pharmacokinetic studies in the clinical phase of experimentation with anti-arrhythmia agents].
作者信息
Jaillon P
出版信息
Arch Mal Coeur Vaiss. 1981 Dec;74 Spec No:57-64.
PMID:6803702
Abstract
摘要
相似文献
1
[Importance of pharmacokinetic studies in the clinical phase of experimentation with anti-arrhythmia agents].[药代动力学研究在抗心律失常药物临床试验阶段的重要性]
Arch Mal Coeur Vaiss. 1981 Dec;74 Spec No:57-64.
2
Clinical application of pharmacokinetics for antiarrhythmic drugs.抗心律失常药物的药代动力学临床应用。
Arch Mal Coeur Vaiss. 1981 Dec;74 Spec No:65-72.
3
Drug therapy of cardiac arrhythmias.心律失常的药物治疗
Cardiol Clin. 1983 May;1(2):305-22.
4
[Epidemiology and experimentation of anti-arrhythmia drugs].[抗心律失常药物的流行病学与实验研究]
Recenti Prog Med. 1986 Jul-Aug;77(7-8):380-9.
5
[Therapy of arrhythmias. New anti-arrhythmia agents].
Verh Dtsch Ges Herz Kreislaufforsch. 1981;47:18-33.
6
Tocainide for arrhythmias.妥卡尼用于治疗心律失常。
Med Lett Drugs Ther. 1985 Feb 1;27(680):9-11.
7
[Active metabolites of anti-arrhythmia drugs].
Postepy Hig Med Dosw. 1985 Mar-Apr;39(2):133-49.
8
The clinical pharmacology of antiarrhythmic drugs.抗心律失常药物的临床药理学。
Cardiovasc Clin. 1984;14(3):153-90.
9
[Therapy control in cardiology: serum level monitoring].[心脏病学中的治疗控制：血清水平监测]
Z Kardiol. 1984 Oct;73(10):605-12.
10
[Protocol-guide in clinical experimentation on anti-arrhythmia agents].[抗心律失常药物临床试验方案指南]
G Ital Cardiol. 1985 Jul;15(7):711-7.
Zotero 插件